Sibylla Biotech Competitors and Similar CompaniesClear all
Sibylla Biotech's competitors and similar companies include AEON Biopharma and Cingulate.
 AEON Biopharma AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology. |  Cingulate Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety. | ||
Founding Date | Founding Date 2017 | Founding Date 2012 | Founding Date 2021 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Verona, IT HQ | Locations Irvine, US HQ Newport Beach, US | Locations Kansas City, US HQ Morristown, US |
Employees | Employees 383% decrease | Employees 6 | Employees 13 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 39.5 m | Valuation ($) 13.2 m |
Financial | |||
Net income | Net income N/A | Net income ($39.2m) (FY, 2025) | Net income ($22.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 22.5m | Total funding raised $ 112.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
AEON Biopharma
HQ
Irvine, US
Employees
6
AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology.
View companyCingulate
HQ
Kansas City, US
Employees
13
Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety.
View company